• SENSEX
    NIFTY 50

Pfizer seeks expedited approval pathway for its COVID-19 vaccine in India

Updated : May 04, 2021 01:31:24 IST

Indian government insists on foreign vaccine makers conducting domestic clinical trials
Pfizer withdrew its application in February this year over India's rule mandating drug makers to conduct local clinical trials
Pfizer seeks expedited approval pathway for its COVID-19 vaccine in India
Published : May 04, 2021 01:31 PM IST

You May Also Like

Live TV

recommended for you

Advertisement